NovaBay Pharma (NBY) Receives $1.5M of Additional Financing Via Equity Offering
NovaBay Pharmaceuticals, Inc. (NYSE: NBY), announced the receipt of a $1.5 million equity investment from Pioneer Pharma (Singapore) Pte. Ltd., an affiliate of Naqu Area Pioneer Pharma Co., Ltd., a Shanghai-based company that markets high-end pharmaceutical products into China. As part of the expansion of the NeutroPhase distribution agreement for Southeast Asia announced on September 14, 2012, Pioneer has completed its investment of $2.5 million. Pioneer has the right to invest an additional $3.0 Million on or before August 31, 2013.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clinical Data Presented at ARVO Showing NovaBay’s Avenova Reduces Bacteria on Ocular Skin Surface by More than 90%
- Axiall Corp. (AXLL) Announces Filing of Definitive Proxy Materials; Affirms Ongoing Talks with Multiple Parties
- 22nd Century Group (XXII) Notes Lawsuit Filed by Crede CG III Following JV Termination; Calls 'Frivolous'
Create E-mail Alert Related CategoriesCorporate News, Market Check
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!